Roivant Sciences's total assets for Q2 2024 were $6.21B, a decrease of -4.47% from the previous quarter. ROIV total liabilities were $625.99M for the fiscal quarter, a 4.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.